Last Update Time:
13-Mar-2025 16:00:00
ISIN:
INE0MRE01011
Sector:
Healthcare
Symbol:
INFINIUM
Infinium Pharmachem Limited
₹226.00
₹2.50
(1.12%)
▲
Prev. Close
₹223.50
Open
₹225.50
Close
₹224.65
Range
₹214.70 - ₹237.30
High
₹226.00
Low
₹221.00
Ind. Close
₹0.00
VWAP
₹223.92
The current stock price of Infinium Pharmachem Limited is ₹226.00, with a target price range between ₹214.70 and ₹237.30. The stock has experienced a price change of ₹2.50 (1.12%), reflecting recent market volatility.
Today's opening price was ₹225.50, while the previous close stood at ₹223.50.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Infinium Pharmachem Limited Price Chart
Infinium Pharmachem Limited Pre Open Market Overview: 13-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 0
- Previous Close Price: 223.5
- Change: -223.50%
- Total Traded Volume: 0
- Total Buy Quantity: 1,000
- Total Sell Quantity: 1,000
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 0.00 | 0.00 | 0.00 |
| 217.25 | 500.00 | 0.00 |
| 220.10 | 500.00 | 0.00 |
| 228.00 | 0.00 | 500.00 |
| 228.45 | 0.00 | 500.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 1000
Total Sell Quantity: 1000
Shareholding Patterns of Infinium Pharmachem Limited
Key Trade Statistics of Infinium Pharmachem Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.04 |
| Traded Value (₹ Cr.) | 0.08 |
| Total Market Cap (₹ Cr.) | 352.18 |
| Free Float Market Cap (₹ Cr.) | 84.55 |
| Impact cost | N/A |
| Quantity Traded | 3,500.00 |
| Deliverable Quantity | 3,500.00 |
| % of Quantity to Traded | 100 |
| Security VaR | N/A |
| Index VaR | N/A |
| VaR Margin | 50 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 53.5 |
| Face Value | 10 |
Key Price Statistics of Infinium Pharmachem Limited
The 52-week high for Infinium Pharmachem Limited was ₹392.50, recorded on 04-Oct-2024. On the other hand, the 52-week low stands at ₹178.05, with the lowest value recorded on 02-Aug-2024.
The upper band for trading is ₹234.65, and the lower band is ₹212.35. The price band is 5%.
The stock's daily volatility stands at N/A, while the annualized volatility is N/A. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (04-Oct-2024) | 392.50 |
| 52 Week Low (02-Aug-2024) | 178.05 |
| Upper Band | 234.65 |
| Lower Band | 212.35 |
| Price Band (%) | 5 |
| Daily Volatility | - |
| Annualised Volatility | - |
| Tick Size | 0.05 |
Key Securities Statistics of Infinium Pharmachem Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 17-Apr-2023 |
| Adjusted P/E | 34.83 |
| Symbol P/E | 34.83 |
| Index | NIFTY SME EMERGE |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Infinium Pharmachem Limited
| Title | Details |
|---|---|
| Board Status | SME |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Infinium Pharmachem Limited
| Subject | Date |
|---|---|
| Statement of deviation(s) or variation(s) under Reg. 32 | 04-Mar-2025 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 10-Jan-2025 |
| Updates | 10-Jan-2025 |
| Reply to Clarification- Financial results | 19-Dec-2024 |
| Clarification - Financial Results | 11-Dec-2024 |
| Financial Result Updates | 14-Nov-2024 |
| Outcome of Board Meeting | 14-Nov-2024 |
| Board Meeting Intimation | 06-Nov-2024 |
Corporate Actions of Infinium Pharmachem Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | ANNUAL GENERAL MEETING | 23-Sep-2024 |
| 10 | BONUS 1:1 | 13-Sep-2023 |
Board Meetings of Infinium Pharmachem Limited
Financial Results of Infinium Pharmachem Limited
Company Directory of Infinium Pharmachem Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| - | Registered Address | 38 G.I.D.C Sojitra Taluka - Sojitra ANAND - 387240 ANAND | ANAND |
| - | Corporate Office | Suite 205, Sigma Prime 2nd Floor, Nr. Sardar Patel Statue Vallabh Vidhyanagar ANAND - 388120 ANAND | ANAND |
| - | Transfer Agent | Office No. S6 - 2, 6th Floor Pinnacle Business Park, Next to Ahura Centre Mahakali Cav MUMBAI - 400093 MUMBAI | MUMBAI |
Insider Trading of Infinium Pharmachem Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type | ||
|---|---|---|---|---|---|
| No insider trading information available | |||||
Annual Reports of Infinium Pharmachem Limited
Investor Complaints of Infinium Pharmachem Limited
Event Calendar of Infinium Pharmachem Limited
| Purpose | Details |
|---|---|
| Board Meeting Intimation | INFINIUM PHARMACHEM LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Other business. |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
| INFINIUM PHARMACHEM LIMITED has informed the Exchange about Board Meeting to be held on 01-Oct-2024 to consider Fund raising. | Board Meeting Intimation |
| Fund Raising | Board Meeting to Consider and approve the issue of equity shares by way of preferential issue in accordance with rules and regulations of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 as amended subject to the approval of the shareholders and necessary regulatory approvals. |
| INFINIUM PHARMACHEM LIMITED has informed the Exchange about Board Meeting to be held on 02-Sep-2024 to consider Other business. | Board Meeting Intimation |
| Other business matters | To consider other business matters |
| INFINIUM PHARMACHEM LIMITED has informed the Exchange about Board Meeting to be held on 07-Jun-2024 to consider Fund raising. | Board Meeting Intimation |
| Fund Raising/Other business matters | 1. To consider and approve issue of 19,56,000 fully convertible warrants on preferential basis subject to approval of members.2. To consider and approve investments, giving loans & guarantees and security in excess of limits specified under section 186 of the Companies Act, 2013.3. To consider and approve for giving loan or guarantee or providing security in connection with loan availed by any of the company's subsidiary(ies) or any other person specified under section 185 of the companies Act, 2013.4. To consider and approve investment in M/s Infinium Healthcare Pvt. Ltd, making it a subsidiary of the Company. |
| Financial Results/Other business matters | To consider and approve the audited financial results for the period ended March 31, 2024 and other business matters |
| Other business matters | To review business operations of the Company. |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Bonus/Other business matters | To consider allotment of bonus shares and other business matters |
| Bonus/Other business matters | To consider bonus and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2023 and other business matters |
Share Transfers of Infinium Pharmachem Limited
Voting Results of Infinium Pharmachem Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 23-OCT-2024 | EGM | To issue equity shares by way of Preferential Issue |
| 28-SEP-2024 | AGM | To receive, consider and adopt the audited standalone and consolidated financial statements of the company for the financial year ended march 31, 2024 and the reports of the board of directors and auditors thereon. |
| 28-SEP-2024 | AGM | Ratification of remuneration to the cost auditors for the financial year 2024-25: |
| 28-SEP-2024 | AGM | To appoint a director in place of Mr. Pravin Bhadabhai Madhani (DIN: 00370791), who retires by rotation and being eligible, offers himself for re-appointment: |
| 06-JUL-2024 | EGM | To issue securities (Fully Convertible Warrants) on a Preferential Issue Basis |
| 06-JUL-2024 | EGM | Approval of loan and investment under section 186 of the companies act, 2013 |
| 06-JUL-2024 | EGM | To approve transactions under section 185 of the Companies Act, 2013 |
| 28-AUG-2023 | AGM | To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the financial year ended March 31, 2023 and the Reports of the Board of Directors and Auditors thereon |
| 28-AUG-2023 | AGM | To appoint a Director in place of Mr. Mitesh Lavjibhai Chikhaliya (DIN: 03342934), who retires by rotation and being eligible, offers himself for re-appointment |
| 28-AUG-2023 | AGM | Approval of Related party transactions to be entered in the F.Y. 2023-24 |
| 28-AUG-2023 | AGM | Increase in Authorised share capital of the company and alteration of capital clause of Memorandum of association of the company |
| 28-AUG-2023 | AGM | Approval of Bonus Issue to the shareholders of the company |
| 28-AUG-2023 | AGM | Ratification of remuneration to the Cost Auditors for the financial year 2023-24 |
FAQs on Infinium Pharmachem Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.